转移性结直肠癌患者循环肿瘤细胞、癌胚抗原与总生存期的关系。 - Suppr | 超能文献

Relationship among circulating tumor cells, CEA and overall survival in patients with metastatic colorectal cancer.

出版信息

Ann Oncol. 2013 Oct;24(10):2708-2710. doi: 10.1093/annonc/mdt404. Epub 2019 Dec 4.

DOI:10.1093/annonc/mdt404

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Relationship among circulating tumor cells, CEA and overall survival in patients with metastatic colorectal cancer.转移性结直肠癌患者循环肿瘤细胞、癌胚抗原与总生存期的关系。

Ann Oncol. 2013 Oct;24(10):2708-2710. doi: 10.1093/annonc/mdt404. Epub 2019 Dec 4.

2

Correlation between circulating tumor DNA and carcinoembryonic antigen levels in patients with metastatic colorectal cancer.转移性结直肠癌患者循环肿瘤 DNA 与癌胚抗原水平的相关性。

Cancer Med. 2021 Dec;10(24):8820-8828. doi: 10.1002/cam4.4384. Epub 2021 Nov 24.

3

Clinico-pathological correlation of serial measurement of circulating tumor cells in 24 metastatic colorectal cancer patients receiving chemotherapy reveals interpatient heterogeneity correlated with CEA levels but independent of KRAS and BRAF mutation.对24例接受化疗的转移性结直肠癌患者循环肿瘤细胞的系列测量结果进行临床病理相关性分析，结果显示患者间的异质性与癌胚抗原（CEA）水平相关，但与KRAS和BRAF突变无关。

Cancer Biol Ther. 2015;16(5):709-13. doi: 10.1080/15384047.2015.1030555.

4

CEA, CA19-9, circulating DNA and circulating tumour cell kinetics in patients treated for metastatic colorectal cancer (mCRC).癌胚抗原（CEA）、CA19-9、循环 DNA 和循环肿瘤细胞动力学在转移性结直肠癌（mCRC）患者治疗中的变化。

Br J Cancer. 2021 Aug;125(5):725-733. doi: 10.1038/s41416-021-01431-9. Epub 2021 Jun 10.

5

Molecular detection of circulating tumor cells in the peripheral blood of patients with colorectal cancer using RT-PCR: significance of the prediction of postoperative metastasis.应用逆转录聚合酶链反应检测结直肠癌患者外周血循环肿瘤细胞：对术后转移预测的意义

World J Surg. 2006 Jun;30(6):1007-13. doi: 10.1007/s00268-005-0485-z.

6

The relationship between circulating carcinoembryonic antigen (CEA) levels and parameters of primary tumor and metastases in breast cancer patients.乳腺癌患者循环癌胚抗原（CEA）水平与原发肿瘤及转移灶参数之间的关系。

Med Arh. 2004;58(1):23-6.

7

Increased detection of circulating tumor cells in the blood of colorectal carcinoma patients using two reverse transcription-PCR assays and multiple blood samples.使用两种逆转录聚合酶链反应检测方法和多份血样增加对结直肠癌患者血液中循环肿瘤细胞的检测。

Clin Cancer Res. 1999 Dec;5(12):4158-63.

8

Detection of colonic cells in peripheral blood of colorectal cancer patients by means of reverse transcriptase and polymerase chain reaction.通过逆转录酶和聚合酶链反应检测结直肠癌患者外周血中的结肠细胞。

Br J Cancer. 1998 Nov;78(10):1368-72. doi: 10.1038/bjc.1998.686.

9

Comparative analysis of tumor markers and evaluation of their predictive value in patients with colorectal cancer.结直肠癌患者肿瘤标志物的比较分析及其预测价值评估

Onkologie. 2012;35(3):108-13. doi: 10.1159/000336816. Epub 2012 Feb 20.

10

Are high initial CEA and CA 19-9 levels associated with the presence of K-ras mutation in patients with metastatic colorectal cancer?转移性结直肠癌患者的高初始癌胚抗原（CEA）和糖类抗原19-9（CA 19-9）水平是否与K-ras基因突变的存在相关？

Tumour Biol. 2013 Aug;34(4):2233-9. doi: 10.1007/s13277-013-0763-6. Epub 2013 Apr 28.

引用本文的文献

1

CD133 Expression in Circulating Tumor Cells as a Prognostic Marker in Colorectal Cancer.循环肿瘤细胞中CD133表达作为结直肠癌的预后标志物

Int J Mol Sci. 2025 May 15;26(10):4740. doi: 10.3390/ijms26104740.

2

Presence of CD44v9-Expressing Cancer Stem Cells in Circulating Tumor Cells and Effects of Carcinoembryonic Antigen Levels on the Prognosis of Colorectal Cancer.循环肿瘤细胞中表达CD44v9的癌症干细胞的存在及癌胚抗原水平对结直肠癌预后的影响

Cancers (Basel). 2024 Apr 19;16(8):1556. doi: 10.3390/cancers16081556.

3

Circulating lncRNA EGFR-AS1 as a diagnostic biomarker of colorectal cancer and an indicator of tumor burden.循环lncRNA EGFR-AS1作为结直肠癌的诊断生物标志物和肿瘤负荷指标。

J Gastrointest Oncol. 2022 Oct;13(5):2439-2446. doi: 10.21037/jgo-22-968.